U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003451) titled 'Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients' on May 26.
Brief Summary: - Assess KL-6 and Calprotectin as novel biomarkers for diagnosis of ILD among Rheumatoid arthritis patients
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
Rheumatoid Arthritis
Interstitial Lung Disease
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Waleed Gamal Elddin Khaleel, Assiut University
Disclaimer: Curated by HT Syndication....